Systemic glucocorticoids in the treatment of COVID-19 and risks of adverse outcomes in COVID-19 patients in the primary and secondary care setting (Corticosteroids in COVID19)

First published 22/12/2020

Last updated 12/06/2024

EU PAS number:

EUPAS38759

Study

Finalised

Documents

Study protocol

Initial protocol

COVID 19 and steroid treatments_v4.0 clean

English (1.3 MB - PDF)View document

Updated protocol

COVID 19 and steroid treatments_v5.0 Clean

First published: 22/02/2024

English (1.26 MB - PDF)View document

Study results

ECORE Final results v1.0

English (4.93 MB - PDF)View document

Study report

Other information

Study, other information

COVID-19 Report 1_v2.0 Clean

English (621.59 KB - PDF)View document

Multicentre collaboration for COVID - Report 4 v1.0 - 27 sept 2021

English (385.21 KB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs